Rapport Therapeutics, Inc. RAPP Business Segments
| FY'25 | FY'24 | ||
|---|---|---|---|
| Research And Development Expense by Product | |||
| Other Costs | $6.68M+137% | $2.82M+85.2% | |
| Preclinical Programs External Expenses | $16.57M+0.2% | $16.54M+161% | |
| RAP219Program External Expenses | $41.14M+86.3% | $22.08M+116% | |
| Research And Development Personnel Related Costs Including Stock-Based Compensation | $30.4M+55.9% | $19.5M+96.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Rapport Therapeutics, Inc. break its business down?
- Rapport Therapeutics, Inc. (RAPP) reports selling general and administrative expense by product across 3 parts — Facility Related And Other, General And Administrative Personnel Related Costs Including Stock-Based Compensation and Professional And Consulting Costs. Each is extracted from the segment footnotes and tracked over time.
- Where does Rapport Therapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Rapport Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.